Point72 Asset Management
KALA icon

Point72 Asset Management’s KALA BIO KALA Stock Holding History

Point72 Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-124
Closed -$1.14M – 933
2019
Q4 		$1.14M Hold
124
– – 0.01% 694
2019
Q3 		$1.18M Buy
+124
New +$1.51M 0.01% 667
2019
Q2 		– Sell
-125
Closed -$2.58M – 1438
2019
Q1 		$2.58M Buy
+125
New +$2.22M 0.01% 673
2018
Q1 		– Sell
-20
Closed -$925K – 1034
2017
Q4 		$925K Buy
+20
New +$936K ﹤0.01% 810

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management's KALA Position: Q1 2020 in Review

Point72 Asset Management sold out of KALA BIO (KALA) in Q1 2020, closing a stake of 124 shares — an estimated $1.14M sold.

Point72 Asset Management first reported a position in KALA in Q4 2017 and held it in 4 quarters. The position peaked at $2.58M in Q1 2019. 83 funds tracked by Wall St. Rank hold KALA as of Q1 2020.

  • Point72 Asset Management reported no remaining KALA BIO position as of Q1 2020 after selling out during the quarter.
  • Point72 Asset Management sold 124 KALA BIO shares in Q1 2020, an estimated $1.14M.
  • Point72 Asset Management first reported a position in KALA BIO in Q4 2017 and held it in 4 quarters.
  • Point72 Asset Management's KALA BIO position peaked at $2.58M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held KALA BIO as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.